Clinical Trial Update: Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial evaluated the effects of cholecalciferol (vitamin D3) and soy isoflavones in patients with Irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Cholecalciferol (Vitamin D3)
• Soy Isoflavones (isoflavones from soy)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Irritable Bowel Disease | Phase 4 | Status: COMPLETED